Contineum Therapeutics (CTNM) Net Equity Issued and Repurchased (2023 - 2026)
Contineum Therapeutics (CTNM) posted Net Equity Issued and Repurchased of $20.53 million for Q3 2026, up 7.0% from $19.19 million a year earlier.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Equity Issued and Repurchased at Contineum Therapeutics was $3.19 million, down 84.1% year-over-year; for FY2025, it was $686,000, down 13.2% from FY2024.
- In prior years, Contineum Therapeutics' Net Equity Issued and Repurchased was $790,000 in FY2024 (-98.7%) and $60.27 million in FY2023.
- The Q3 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
- On a year-over-year basis, Net Equity Issued and Repurchased has increased in each of the last three quarters, with growth averaging 184.2% over the last five quarters.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $1.25 million (Q2 2026), $198,000 (Q1 2026) and -$18.79 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 20.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.53 Mn |
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 198,000.00 |
| Dec 31, 2025 | -18.79 Mn |
| Sep 30, 2025 | 19.19 Mn |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 642,000.00 |
| Sep 30, 2024 | -108.20 Mn |
| Jun 30, 2024 | 108.22 Mn |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 10.33 Mn |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 8,000.00 |
API Access
Contineum Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();